There was no significant difference in physician and patient evaluations for both drugs. In the present study we designed the study protocol to compare the efficacy and safety of the most common employed drugs metamizole sodium and diclofenac sodium and to evaluate the current practice of urinary colic pain management in a double-blind, observational, two-center study design.
Results: Both of the treatment groups were homogeneous when analyzed by age, sex and baseline pain intensity. Both treatments were well tolerated and none of the observed side effects were serious. Five patients in the metamizole sodium and three patients in the diclofenac group needed extra treatment. The average pain intensity difference between groups for all time points measured was not significantly different.
There was no significant difference in physician and patient evaluations for both drugs. Renal colic is one of the most frequent reasons for emergency department visits. Clinically the pain intensity is very high and needs to be treated immediately with appropriate analgesics. In available countries such as Turkey, Brazil and Spain, metamizole sodium (dipyrone) is one of the most frequently used first line analgesic agents for colic pain (1) . Another first line drug is diclofenac and is also employed commonly in renal colic pain by parenteral route (1) Due to the high intensity of pain in renal colic, the main goal of the physicians is to decrease the pain intensity as soon as possible. In emergency service conditions, diclofenac sodium is the drug of choice in the management of renal colic pain.
However, it has been reported recently that
Increased side effects such as dyspeptic complaints, nausea and gastrointestinal (GI) irritation, as well as reporting of GI bleeding, hypertension, stroke, tissue necrosis (2), cardiac symptoms (3), and different degrees of anaphylactic reactions (4-6) have led to the re-emergence of alternative therapies (7, 8) . In early and recent discussions, there are arguments that metamizole sodium at a standard dose of 1 g fails to effect immediately (9) (10) (11) . A search in the literature about comparative studies shows that there are conflicting results (1, (12) (13) (14) . In a study different i.m. doses of metamizole sodium (1 g, 2 g) and diclofenac sodium (75 mg) were found equally effective (15) . However in a meta-analysis by Edwards et al. It is stated that single dose metamizole sodium was of similar efficacy to other analgesics used in renal colic pain although intramuscular metamizole sodium was less effective than diclofenac 75 mg (1) .
In the present study we designed the study protocol to compare the efficacy and safety of the most common employed drugs metamizole sodium and diclofenac sodium and to evaluate the current practice of urinary colic pain management in a double-blind, observational, two-center study design.
MATERIAL and METHOD
This double-blind observational study was conducted after Institutional review board approval, in the emergency services of Numune State and İbn-i Sina University Hospitals in Ankara, Turkey. The study was performed in accordance with the Declaration of Helsinki.
Subjects and inclusion criteria
During the data collection period of our study (two months) patients who were diagnosed with renal colic and received only metamizole or only diclofenac treatment were admitted to the study.
The primary emergency department physicians were aware of the study, but they were asked not to be affected in choosing any treatment option for acute 
Exclusion criteria
Patients were excluded if they had pre-treatment with any spasmolytic or analgesic drug in the previous 12-hours, contraindications for the usage of metamizole sodium or any other NSAIDs, any preexisting disease or conditions and/or any concomitant Figure 1 . Distribution of the patients in the study groups. Total of 88 adult patients including male (n=52) and female (n=36) patients with renal colic pain, aged between 18 -65, were enrolled in the study. Forty-eight of (55%) patients received metamizole sodium 1 gr and 40 (45%) of patients received diclofenac sodium 75 mg via i.m. route. Rescue treatment was required for 5 patients (10 %) in metamizole sodium group and in 3 patients (8 %) in diclofenac sodium group. Data obtained from the patients who needed rescue medicine were not included in final statistical evaluation Blood pressure was also monitorized synchronously at the pain measurement time points.
Patients were observed for at least 2 hours. The data of the patients who did not respond to the study medication and who needed a rescue treatment (according to the primary emergency department physician) was excluded from further analysis.
Patient and physicians satisfaction
At the end of the observation period (2 hours), both the patient and the investigator (observing physician, n=4) were asked to evaluate the effectiveness of the study drug by using a 4-point rating scale: not effective (1), slightly effective (2), effective (3), very effective (4) and excellent (5). 
Statistical methods

RESULTS
Total of 88 adult patients including, 35 female (40%) and 53 male (60%) were enrolled into the study. Sex, age and baseline pain intensities were not significantly different in either of the treatment groups or between the study centers. The demographic data for both groups were tabulated in Table 1 .
Forty-eight (55%) patients received metamizole sodium 1 gr and 40 (45%) patients received diclofenac sodium 75 mg via i.m. route.
Rescue treatment was required for five patients (10%) of metamizole sodium group and for three patients (8%) of diclofenac sodium group.
The differences between the treatment groups were insignificant for all time points measured.
Neither the results of the visual analogue scale nor the 5-point verbal score showed difference between the two treatment groups (Figure 2 and 3 ). There was a good correlation between the methods used to measure the pain intensity (r=0,93)
The evaluation of the study drugs by the patient and the investigator, who was uninformed about study drugs, did not differ between the two groups. The average patient satisfaction scores (± SEM) were 3,88 (0,10) and 4,11 (0,11) for metamizole sodium and diclofenac groups, respectively. The average physician satisfaction scores (± SEM) were 4,09 (0,07) and 4,30 (0,11) for metamizole sodium and diclofenac groups, respectively. The median score for both patient and physician satisfaction score for both groups was 4.
Both treatments were well tolerated and none of the observed side effects were serious. None of the patients in each group had any significant blood pressure change. 
METAMIZOLE VS DICLOFENAC IN RENAL COLIC
DISCUSSION
In a previous study, metamizole sodium (1 g) and diclofenac sodium (75 mg) were compared in acute renal colic and the efficacies of the drugs were found to be equipotent (15) . In the same study, another group of patients received 2 g of metamizole sodium
and the efficacies of the drug was found almost equivalent to 1 g metamizole sodium and 75 mg diclofenac sodium (15) . Therefore, this study was designed in two groups as 1 g metamizole sodium and 75 mg diclofenac sodium via i.m. route, which are also the daily practices in most of the emergency departments in Turkey.
Despite intense studies (12, (14) (15) (16) (17) and a meta- found that 1 g of metamizole sodium is as effective as 2 g metamizole sodium in pain management in the previous studies, it is obvious that lowering the dosage will effect the onset and as well as the duration of the efficacy of the drug (16) . In the present study, we found that the analgesic action of metamizole sodium becomes apparent slightly slower than diclofenac. This may be the reason why the physicians have the misperception that metamizole sodium is less effective than diclofenac, as they are primarily focused on the immediate pain relief.
In the study, pain measurement time points were set at standard minutes after drug intake (30, 60, 90 and 120 minutes). There was not any statistically significant difference at these time points between the treatment groups. However, any differences which This results indicates that the adverse effects should always be kept in mind in addition to their efficacy.
Another important point in renal colic pain management is the cost of the overall treatment.
Especially for frequently seen disorders it has a tremendous impact from the societal perspective.
Small differences in cost are growing with the high prevalence rate. In our study, design of the pharmacoeconomic impact of these treatment options was not analyzed. However, a rough cost analysis of a single injection of metamizole sodium or diclofenac showed that metamizole sodium has an apparent lower cost than diclofenac sodium.
In this study, 1 g metamizole sodium, which is 13% of the daily maximum and 33% of a single therapeutic dose was used. In contrast, 75 mg diclofenac sodium is 50% of the daily maximum and 100% of a single therapeutic dose. This provides an advantage when metamizole sodium is employed for both the patient and the physician to continue with the same drug after initial treatment, when needed. 
